IGF1R and neoplasm: In good agreement with two previously published studies using other anti-IGF1R antibodies [8, 9] (giving confidence on the selectivity of the antibodies used), results from Human Protein Atlas showed a membranous and cytoplasmic expression of IGF1R by epithelial tumor cells together with an absence of expression by stromal cells (Additional file 4: Figure S3a, right panel).